Report Detail

Pharma & Healthcare Global Fertility Enhancing Treatment Market Growth (Status and Outlook) 2019-2024

  • RnM3282639
  • |
  • 08 April, 2019
  • |
  • Global
  • |
  • 134 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
The classification of Fertility Enhancing Treatment includes Fertility Drugs for Women, Fertility Drugs for Men and OTC Conception Gels/Lubricants, and the proportion of Fertility Drugs for Women in 2017 is about 88%.
North America and Europe are the two largest consumption place, with a similar consumption market share nearly 33% in 2017. Following North America and Europe, China is the third consumption place with the consumption market share of 9.4%.

According to this study, over the next five years the Fertility Enhancing Treatment market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 5600 million by 2024, from US$ 4380 million in 2019. In particular, this report presents the global revenue market share of key companies in Fertility Enhancing Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Fertility Enhancing Treatment market by product type, application, key companies and key regions.

This study considers the Fertility Enhancing Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Fertility Drugs for Women
Fertility Drugs for Men
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Drug Stores
Online

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Church&Dwight
SASMAR
BioFilm,Inc
FAIRHAVEN HEALTH
The YES YES Company

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Fertility Enhancing Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Fertility Enhancing Treatment market by identifying its various subsegments.
Focuses on the key global Fertility Enhancing Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fertility Enhancing Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Fertility Enhancing Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Fertility Enhancing Treatment Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Fertility Enhancing Treatment Market Size 2014-2024
        • 2.1.2 Fertility Enhancing Treatment Market Size CAGR by Region
      • 2.2 Fertility Enhancing Treatment Segment by Type
        • 2.2.1 Fertility Drugs for Women
        • 2.2.2 Fertility Drugs for Men
        • 2.2.3 OTC Conception Gels/Lubricants
      • 2.3 Fertility Enhancing Treatment Market Size by Type
        • 2.3.1 Global Fertility Enhancing Treatment Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Fertility Enhancing Treatment Market Size Growth Rate by Type (2014-2019)
      • 2.4 Fertility Enhancing Treatment Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Drug Stores
        • 2.4.3 Online
      • 2.5 Fertility Enhancing Treatment Market Size by Application
        • 2.5.1 Global Fertility Enhancing Treatment Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Fertility Enhancing Treatment Market Size Growth Rate by Application (2014-2019)

      3 Global Fertility Enhancing Treatment by Players

      • 3.1 Global Fertility Enhancing Treatment Market Size Market Share by Players
        • 3.1.1 Global Fertility Enhancing Treatment Market Size by Players (2017-2019)
        • 3.1.2 Global Fertility Enhancing Treatment Market Size Market Share by Players (2017-2019)
      • 3.2 Global Fertility Enhancing Treatment Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Fertility Enhancing Treatment by Regions

      • 4.1 Fertility Enhancing Treatment Market Size by Regions
      • 4.2 Americas Fertility Enhancing Treatment Market Size Growth
      • 4.3 APAC Fertility Enhancing Treatment Market Size Growth
      • 4.4 Europe Fertility Enhancing Treatment Market Size Growth
      • 4.5 Middle East & Africa Fertility Enhancing Treatment Market Size Growth

      5 Americas

      • 5.1 Americas Fertility Enhancing Treatment Market Size by Countries
      • 5.2 Americas Fertility Enhancing Treatment Market Size by Type
      • 5.3 Americas Fertility Enhancing Treatment Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Fertility Enhancing Treatment Market Size by Countries
      • 6.2 APAC Fertility Enhancing Treatment Market Size by Type
      • 6.3 APAC Fertility Enhancing Treatment Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Fertility Enhancing Treatment by Countries
      • 7.2 Europe Fertility Enhancing Treatment Market Size by Type
      • 7.3 Europe Fertility Enhancing Treatment Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Fertility Enhancing Treatment by Countries
      • 8.2 Middle East & Africa Fertility Enhancing Treatment Market Size by Type
      • 8.3 Middle East & Africa Fertility Enhancing Treatment Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Fertility Enhancing Treatment Market Forecast

      • 10.1 Global Fertility Enhancing Treatment Market Size Forecast (2019-2024)
      • 10.2 Global Fertility Enhancing Treatment Forecast by Regions
        • 10.2.1 Global Fertility Enhancing Treatment Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Fertility Enhancing Treatment Forecast by Type
      • 10.8 Global Fertility Enhancing Treatment Forecast by Application

      11 Key Players Analysis

      • 11.1 Merck
        • 11.1.1 Company Details
        • 11.1.2 Fertility Enhancing Treatment Product Offered
        • 11.1.3 Merck Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Merck News
      • 11.2 Ferring
        • 11.2.1 Company Details
        • 11.2.2 Fertility Enhancing Treatment Product Offered
        • 11.2.3 Ferring Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Ferring News
      • 11.3 MSD
        • 11.3.1 Company Details
        • 11.3.2 Fertility Enhancing Treatment Product Offered
        • 11.3.3 MSD Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 MSD News
      • 11.4 LIVZON
        • 11.4.1 Company Details
        • 11.4.2 Fertility Enhancing Treatment Product Offered
        • 11.4.3 LIVZON Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 LIVZON News
      • 11.5 Abbott
        • 11.5.1 Company Details
        • 11.5.2 Fertility Enhancing Treatment Product Offered
        • 11.5.3 Abbott Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Abbott News
      • 11.6 Bayer Zydus Pharma
        • 11.6.1 Company Details
        • 11.6.2 Fertility Enhancing Treatment Product Offered
        • 11.6.3 Bayer Zydus Pharma Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Bayer Zydus Pharma News
      • 11.7 Church&Dwight
        • 11.7.1 Company Details
        • 11.7.2 Fertility Enhancing Treatment Product Offered
        • 11.7.3 Church&Dwight Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Church&Dwight News
      • 11.8 SASMAR
        • 11.8.1 Company Details
        • 11.8.2 Fertility Enhancing Treatment Product Offered
        • 11.8.3 SASMAR Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 SASMAR News
      • 11.9 BioFilm,Inc
        • 11.9.1 Company Details
        • 11.9.2 Fertility Enhancing Treatment Product Offered
        • 11.9.3 BioFilm,Inc Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 BioFilm,Inc News
      • 11.10 FAIRHAVEN HEALTH
        • 11.10.1 Company Details
        • 11.10.2 Fertility Enhancing Treatment Product Offered
        • 11.10.3 FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 FAIRHAVEN HEALTH News
      • 11.11 The YES YES Company

      12 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Fertility Enhancing Treatment . Industry analysis & Market Report on Fertility Enhancing Treatment is a syndicated market report, published as Global Fertility Enhancing Treatment Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Fertility Enhancing Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,938.98
      4,408.47
      5,877.96
      3,436.74
      5,155.11
      6,873.48
      565,616.40
      848,424.60
      1,131,232.80
      305,902.80
      458,854.20
      611,805.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report